Clinical trials
Completed Leukemia, Myeloid, Acute trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| The First Affiliated Hospital of Soochow University | 5 |
| AbbVie | 2 |
| Bristol-Myers Squibb | 2 |
| Chinese PLA General Hospital | 2 |
| The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2 |
| Apollomics Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Astellas Pharma Singapore Pte. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 51 |
| Myelodysplastic Syndromes | 6 |
| Leukemia | 5 |
| Recurrence | 5 |
| Hematologic Diseases | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Neoplasm, Residual | 2 |
| Anemia, Aplastic | 1 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Chromosome Aberrations | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.